Skip to main content

and
Your search also matched 17 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Pathogenetic mechanisms in vascular dementia

Include preview-only content
  1. Article

    Headache associated with acute ischemic stroke

    Headache occurs frequently in acute ischemic stroke, but its frequency varies widely among different studies. We have prospectively studied headache features in patients with first-ever ischemic acute stroke ...

    Maurizio Paciaroni, Lucilla Parnetti, Paola Sarchielli in The Journal of Headache and Pain (2001)

  2. Article

    Open Access

    19th biennial IPEG Meeting

    Igor Timofeev, Leon Kenemans, P. F. Fabene, A. Ahnaou in Neuropsychiatric Electrophysiology (2016)

  3. Article

    Open Access

    Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

    Tau is an axonal microtubule-binding protein. Tau pathology in brain and increased tau concentration in the cerebrospinal fluid (CSF) are hallmarks of Alzheimer’s disease (AD). Most of tau in CSF is present as...

    Claudia Cicognola, Gunnar Brinkmalm, Jessica Wahlgren in Acta Neuropathologica (2019)

  4. Article

    Open Access

    PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study

    Reducing percutaneous endoscopic gastrostomies with jejunal extension tubes (PEG-J) related complications is vital to the long-term preservation of duodenal levodopa infusion (DLI) in advanced Parkinson’s dise...

    Simone Simoni, Pasquale Nigro, Marta Filidei, Giulia Cappelletti in BMC Neurology (2022)

  5. Article

    Open Access

    Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem)

    Dementia with Lewy bodies (DLB) may represent a diagnostic challenge, since its clinical picture overlaps with other dementia. Two toolkits have been developed to aid the clinician to diagnose DLB: the Lewy Bo...

    Mirella Russo, Claudia Carrarini, Angelo Di Iorio in Neurological Sciences (2022)

  6. Article

    Open Access

    Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease

    Proenkephalin (PENK) and prodynorphin (PDYN) are peptides mainly produced by the striatal medium spiny projection neurons (MSNs) under dopaminergic signaling. Therefore, they may represent candidate biomarkers...

    Peggy Barschke, Samir Abu-Rumeileh, M. H. D. Rami Al Shweiki in Journal of Neurology (2022)

  7. Article

    Open Access

    Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an expert opinion and practical guideline

    No disease-modifying therapies are currently available for Alzheimer’s disease (AD) in Europe. Current evidence from clinical trials testing anti-beta amyloid (Aβ) monoclonal antibodies (mAbs) in patients with...

    Massimo Filippi, Giordano Cecchetti, Annachiara Cagnin in Journal of Neurology (2023)